期刊文献+

江苏省涂阳肺结核患者治疗依从性现状调查及影响因素分析 被引量:6

Analysis of risk factors of adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients in Jiangsu province,China
下载PDF
导出
摘要 目的:探讨江苏省结核病治疗依从性现状并分析其影响因素,为制订有针对性的干预措施提供科学依据。方法:随机抽取13个样本点,各样本点连续性收集2006年1月1日起登记报告的60例涂阳肺结核患者为研究对象,由经过培训的调查员采用结构式调查表进行问卷调查,并分析依从性现状及不规则治疗的影响因素。结果:670名结核病患者在治疗过程中有82人存在不规则服药现象,不规则治疗比例12.2%。不规则服药的主要原因是药物不良反应(37.8%)。患者的文化程度及服药方式是影响依从性的主要影响因素。结论:依从性是当前结核病控制工作的一个重要课题,应当关注重点人群,采取以规范督导为主的综合干预措施降低不规则治疗的风险,提高治愈率。 Objective:To describe the current status of patients' adherence to anti-tuberculosis medications and identify risk factors associated with treatment interruption in Jiangsu,aud provide evidences to explore intervention measures. Methods: 13 counties (districts) were randomly sampled as study sites. On each site,60 sputum smear-positive tuberculosis patients registered since January 1,2006 were selected as study subjects and interviewed by a structured questionnaire. Risk factors associated with non-adherence were analyzed. Results:82 of 670 enrolled pulmonary tuberculosis patients interrupted treatment, accounting for 12.2%. Drug side effect was the most important factor causing patients non-adherence (37.8%). Patients' education and the way of taking medicine were the main influence factors affecting patients' adherence. Conclusion:More importance should be attached to treatment adherence under the current DOTS strategy. Synthetic measures taken to focus groups can reduce the risk for interruption and increase cure rate.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2009年第10期1384-1388,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 中国全球基金结核病项目实施性研究(TB07-014)
关键词 肺结核 治疗 依从性 危险因素 pulmonary tuberculosis treatment adherence risk factor
  • 相关文献

参考文献4

二级参考文献19

  • 1全国结核病流行病学调查指导组 全国结核病流行病学抽样调查办公室.2000年全国流行病结核病抽样调查[J].中国防痨杂志,2002,2(24):65-107.
  • 2钱峰.卫生部公布中国结核病防治社会评价结果[N].健康报,2005-3-23
  • 3端木宏谨.抗结核药物合理使用的有关问题[J].中国防痨杂志,2005,27(1):9-10.
  • 4Schneider E, Laserson KF, Wells CD, et al.Turberculosis along the United States-Mexicoborder, 1993-2001.Rev Panam Salud Publica. 2004, 16(1): 23-24.
  • 5Palwatwicha A. Tuberculosis in Thailand[J]. Respirology. 2001, 6(1):65-70.
  • 6Johansson E, Diwan VK, Huong ND. et al. Staff and patient attributes to tuberculosis and compliance with treatment: an exploratory study in district in Vietnam. Tuber Lung Dis, 1996, 77(2): 178-183.
  • 7Cambanis A, Yassin MA, Ramsay A, et al. Rural poverty and delayed presentation to tuberculosis services in Ethiopia. Trop Med Int Health.2005, 10(4) : 330-335.
  • 8Frederick AD Kaona 1, Mary Tubal, Seter Siziya, et al. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health 2004, 4: 68.
  • 9Hussain Z, Kar P, Husain SA. Antituberculosis drug-induced hepatitis: risk factors, prevention and management. Indian J Exp Biol,2003,41 : 1226-1232.
  • 10Onnerod LP, Horsfleld N. Frequency and type of reactions to antituberculosis drugs: observations in routine treatment. Tuber Lung Dis, 1996,77:37-42.

共引文献240

同被引文献62

引证文献6

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部